Annual Lung SPORE Workshop (Abstract Submission)

Filter submissions
76 submissions
Created First Name Last Name Email Phone Select a Session Topic Abstract Title First Author First Name First Author Last Name Affiliation List of Additional Authors Your Abstract Submission Upload Abstract Special Characters Included? Abstract Review Status Upload Poster Poster Uploaded Operations
Fri, 03/29/2024 - 13:18 Victoria Seewaldt victoria.seewaldt@me.com Session 2: Health Disparities in Lung Cancer The impact of diverse clinical trials personal on the diversity clinical trials participants Victoria Seewaldt City of Hope
  • First Name: Robert
    Last Name: Winn
    Affiliation: Massey Cancer Center
  • First Name: Augusto
    Last Name: Ochoa
    Affiliation: LSU Cancer center
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/31/2024 - 18:56 Loretta Erhunmwunsee lorettae@coh.org 6262187287 Session 2: Health Disparities in Lung Cancer Reducing Racial Residential Segregation Lowers the Risk of Lung Cancer in African Americans Yi Xiao COH
  • First Name: Xiaoke
    Last Name: Zou
    Affiliation: COH
  • First Name: Calvin
    Last Name: Tribby
    Affiliation: COH
  • First Name: Peter
    Last Name: Vien
    Affiliation: COH
  • First Name: Christina
    Last Name: Chang
    Affiliation: COH
  • First Name: Richard
    Last Name: Curley
    Affiliation: COH
  • First Name: Olutola
    Last Name: Akande
    Affiliation: COH
  • First Name: Melinda
    Last Name: Aldrich
    Affiliation: VUMC
  • First Name: Sophia
    Last Name: Wang
    Affiliation: COH
  • First Name: RIck
    Last Name: Kittles
    Affiliation: MSM
  • First Name: Kimlin
    Last Name: Ashing
    Affiliation: COH
  • First Name: Lennie
    Last Name: Wong
    Affiliation: COH
  • First Name: Marta
    Last Name: Jankowska
    Affiliation: COH
  • First Name: Tarik
    Last Name: Benmarhnia
    Affiliation: Scripps Institution of Oceanography
  • First Name: Loretta
    Last Name: Erhunmwunsee
    Affiliation: COH
 Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/04/2024 - 17:35 Matthew Oser matthew_oser@dfci.harvard.edu 9174883166 Session 4: Small Cell Lung Cancer Cyclin A/B RxL Macrocyclic Peptide Inhibitors as a Therapeutic Strategy for Small Cell Lung Cancers with High E2F Activity Shilpa Singh Dana-Farber Cancer Institute
  • First Name: Catherine
    Last Name: Gleason
    Affiliation: Circle Pharma
  • First Name: Min
    Last Name: Fang
    Affiliation: UT Southwestern
  • First Name: Vishal
    Last Name: Khivansara
    Affiliation: UT Southwestern
  • First Name: Shanhai
    Last Name: Xie
    Affiliation: UT Southwestern
  • First Name: Yavuz
    Last Name: Durmaz
    Affiliation: Dana-Farber Cancer Institute
  • First Name: Aniruddha
    Last Name: Sarkar
    Affiliation: Dana-Farber Cancer Institute
  • First Name: Yasmin
    Last Name: Laimon
    Affiliation: BWH
  • First Name: Varunika
    Last Name: Savla
    Affiliation: BWH
  • First Name: James
    Last Name: Aggen
    Affiliation: Circle Pharma
  • First Name: Li-Fen
    Last Name: Liu
    Affiliation: Circle Pharma
  • First Name: Bernard
    Last Name: Levin
    Affiliation: Circle Pharma
  • First Name: Evelyn
    Last Name: Wang
    Affiliation: Circle Pharma
  • First Name: Sabina
    Last Name: Signoretti
    Affiliation: BWH
  • First Name: Alexander
    Last Name: Spektor
    Affiliation: Dana-Farber Cancer Institute
  • First Name: Constantine
    Last Name: Kreatsoulas
    Affiliation: Circle Pharma
  • First Name: Rajinder
    Last Name: Singh
    Affiliation: Circle Pharma
  • First Name: David
    Last Name: Earp
    Affiliation: Circle Pharma
  • First Name: Pablo
    Last Name: Garcia
    Affiliation: Circle Pharma
  • First Name: Deepak
    Last Name: Nijhawan
    Affiliation: UT Southwestern
 Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 13:21 Ramin Salehi-Rad rsalehirad@mednet.ucla.edu 18185715627 Session 3: Immuno-oncology Hyper-Interferon Sensitive influenza induces adaptive immune responses and overcomes resistance to anti-PD-1 in murine NSCLC Ramin Salehi-Rad David Geffen School of Medicine at UCLA
  • First Name: Yushen
    Last Name: Du
    Affiliation: Key Laboratory of Cancer Prevention and Intervention
  • First Name: Tian-Hao
    Last Name: Zhang
    Affiliation: UCLA
  • First Name: Dongdong
    Last Name: Chen
    Affiliation: UCLA
  • First Name: William
    Last Name: Crosson
    Affiliation: UCLA
  • First Name: Abascal
    Last Name: Jensen
    Affiliation: UCLA
  • First Name: Yuan
    Last Name: Shi
    Affiliation: UCLA
  • First Name: Jiang
    Last Name: Hong
    Affiliation: UCLA
  • First Name: Tseng
    Last Name: Yenwen
    Affiliation: UCLA
  • First Name: Liu
    Last Name: Bin
    Affiliation: UCLA
  • First Name: Sun
    Last Name: Ren
    Affiliation: Westlake Laboratory of Life Sciences
  • First Name: Dubinett
    Last Name: Steven
    Affiliation: UCLA
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 15:45 Jessica Konen jessica.marie.konen@emory.edu 4047783558 Session 3: Immuno-oncology, Session 6: Cancer Biology Loss of miR-29 as a mechanism of diminished anti-PD-1 response in lung cancer Jessica Konen Department of Hematology and Medical Oncology , Emory University
  • First Name: Lixia
    Last Name: Diao
    Affiliation: Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center
  • First Name: Jing
    Last Name: Wang
    Affiliation: Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center
  • First Name: Don
    Last Name: Gibbons
    Affiliation: Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center
 Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 11:24 Junghui Koo jkoo22@emory.edu 404-323-3287 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Unlocking Immunochemotherapy Potentials for KRAS and LKB1 Mutant Lung Adenocarcinoma through FAK Inhibition and Immunotherapy with Anti-PD1 Antibody Junghui Koo Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute of Emory University
  • First Name: Carol
    Last Name: Tucker-Burden
    Affiliation: Emory University
  • First Name: Melissa
    Last Name: Roy
    Affiliation: Emory University
  • First Name: Chunzi
    Last Name: Huang
    Affiliation: Emory University
  • First Name: Wei
    Last Name: Zhou
    Affiliation: Emory University
  • First Name: Melissa
    Last Name: Gilbert-Ross
    Affiliation: Emory University
  • First Name: Haian
    Last Name: Fu
    Affiliation: Emory University
  • First Name: Suresh
    Last Name: Ramalingam
    Affiliation: Emory University
  • First Name: Adam
    Last Name: Marcus
    Affiliation: Emory University
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 03:47 Catherine Meador cbmeador@mgh.harvard.edu 9192603477 Session 4: Small Cell Lung Cancer Detecting small cell transformation in patients with advanced EGFR mutant lung adenocarcinoma through epigenomic cfDNA profiling Catherine Meador Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Talal
    Last Name: El Zarif
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Xintao
    Last Name: Qiu
    Affiliation: Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Ji-Heui
    Last Name: Seo
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Matthew
    Last Name: Davidsohn
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Hunter
    Last Name: Savignano
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Gitanjali
    Last Name: Lakshminaranan
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Heather
    Last Name: McClure
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: John
    Last Name: Canniff
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Brad
    Last Name: Fortunato
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Rong
    Last Name: Li
    Affiliation: Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Mandeep
    Last Name: Banwait
    Affiliation: Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Karl
    Last Name: Semaan
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Marc
    Last Name: Eid
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Henry
    Last Name: Long
    Affiliation: Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Yin
    Last Name: Hung
    Affiliation: Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Navin
    Last Name: Mahadevan
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: David
    Last Name: Barbie
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Matthew
    Last Name: Oser
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Zofia
    Last Name: Piotrowska
    Affiliation: Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Toni
    Last Name: Choueiri
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Sylvan
    Last Name: Baca
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Aaron
    Last Name: Hata
    Affiliation: Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • First Name: Matthew
    Last Name: Freedman
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
  • First Name: Jacob
    Last Name: Berchuck
    Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 11:19 Shayna Thomas-Jardin shayna.thomas-jardin@utsouthwestern.edu 2144630651 Session 3: Immuno-oncology The integrated stress response (ISR) pathway coordinately regulates multiple immune checkpoint proteins in lung cancer Shayna Thomas-Jardin Department of Molecular Biology, UT Southwestern Medical Center
  • First Name: Shruthy
    Last Name: Suresh
    Affiliation: Dept of Mol Biology, UTSW
  • First Name: Nicole
    Last Name: Novaresi
    Affiliation: Dept of Mol Biology, UTSW
  • First Name: Lisa
    Last Name: Thomas
    Affiliation: Dept of Mol Biology, UTSW
  • First Name: Cheryl
    Last Name: Lewis
    Affiliation: Harold C. Simmons Comprehensive Cancer Center, UTSW
  • First Name: Chul
    Last Name: Ahn
    Affiliation: Harold C. Simmons Comprehensive Cancer Center, O’Donnell School of Public Health, UTSW
  • First Name: Bret
    Last Name: Evers
    Affiliation: Department of Pathology, UTSW
  • First Name: Luisa Maris
    Last Name: Solis Soto
    Affiliation: Department of Translational Molecular Pathology, UT MD Anderson Cancer Center
  • First Name: Ignacio
    Last Name: Wistuba
    Affiliation: Department of Translational Molecular Pathology, UT MD Anderson Cancer Center
  • First Name: John
    Last Name: Minna
    Affiliation: Harold C. Simmons Comprehensive Cancer Center, Hamon Center for Therapeutic Oncology Research, Department of Pharmacology, UTSW
  • First Name: Kathryn
    Last Name: O'Donnell
    Affiliation: Dept of Mol Biology, Harold C. Simmons Comprehensive Cancer Center, Hamon Center for Regenerative Science and Medicine, UTSW
 Abstract_Submission.pdf Yes Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:57 Nicole Novaresi nicole.novaresi@utsw.edu Session 6: Cancer Biology Monoclonal antibodies targeting PCDH7 inhibit tumor growth and enhance response to MAPK pathway-targeted therapies in non-small cell lung cancer Nicole Novaresi Department of Molecular Biology, UTSW
  • First Name: Poorva
    Last Name: Ghosh
    Affiliation: Department of Molecular Biology, UTSW
  • First Name: Hui
    Last Name: Deng
    Affiliation: The University of Texas Health Science Center at Houston
  • First Name: Xuejun
    Last Name: Fan
    Affiliation: The University of Texas Health Science Center at Houston
  • First Name: Zhiqiang
    Last Name: Ku
    Affiliation: The University of Texas Health Science Center at Houston
  • First Name: Wei
    Last Name: Xiong
    Affiliation: The University of Texas Health Science Center at Houston
  • First Name: Xiaorong
    Last Name: Zhou
    Affiliation: Department of Molecular Biology, UTSW
  • First Name: Jingfei
    Last Name: Zhu
    Affiliation: Department of Molecular Biology, UTSW
  • First Name: Huiyu
    Last Name: Li
    Affiliation: Hamon Center for Therapeutic Oncology Research, UTSW
  • First Name: Mahesh S.
    Last Name: Padanad
    Affiliation: Department of Molecular Biology, UTSW
  • First Name: Bethany
    Last Name: Smith
    Affiliation: Department of Molecular Biology, UTSW
  • First Name: Chul
    Last Name: Ahn
    Affiliation: School of Public Health, UTSW
  • First Name: John D.
    Last Name: Minna
    Affiliation: Hamon Center for Therapeutic Oncology Research, School of Public Health, Department of Pharmacology, UTSW
  • First Name: Zhiqiang
    Last Name: An
    Affiliation: The University of Texas Health Science Center at Houston
  • First Name: Ningyan
    Last Name: Zhang
    Affiliation: The University of Texas Health Science Center at Houston
  • First Name: Kathryn A.
    Last Name: O'Donnell
    Affiliation: Department of Molecular Biology, Harold C. Simmons Comprehensive Cancer Center, Hamon Center for Regenerative Medicine, UTSW
 Abstract_Submission.pdf Yes Approved to be a Speaker
Sun, 03/10/2024 - 20:52 Matthew Wang matthew.wang.mcw69@yale.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Understanding the role of alternative RNA splicing in Osimertinib resistance in lung adenocarcinoma Matthew Wang Department of Molecular Biophysics and Biochemistry, Yale University, USA
  • First Name: Robert
    Last Name: Tesng
    Affiliation: Department of Therapeutic Radiology, Yale University, USA
  • First Name: Li-Ting
    Last Name: Ku
    Affiliation: Department of Therapeutic Radiology, Yale University, USA
  • First Name: Xinning
    Last Name: Shan
    Affiliation: Department of Therapeutic Radiology, Yale University, USA
  • First Name: Joanne
    Last Name: Chen
    Affiliation: Department of Therapeutic Radiology, Yale University, USA
  • First Name: Katerina
    Last Name: Politi
    Affiliation: Department of Pathology, Yale University, USA
  • First Name: Luisa
    Last Name: Escobar-Hoyos
    Affiliation: Department of Molecular Biophysics and Biochemistry, Yale University, USA; Department of Therapeutic Radiology, Yale University, USA
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 20:25 Diane Yang dyang17@mgh.harvard.edu Session 6: Cancer Biology Profiling the protein interactome through cysteine-reactive libraries has revealed the identification of EML4ALK dimerizers Diane Yang Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Stefan
    Last Name: Harry
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Elizabeth
    Last Name: Codd
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Stefan
    Last Name: Kaluziak
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Edwin
    Last Name: Zhang
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Alexander Daniel
    Last Name: Carlin
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Zavontae
    Last Name: Oppong-Holmes
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Wendy
    Last Name: Yang
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Abigail
    Last Name: Smith
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Dawn
    Last Name: Mitchell
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Mariko
    Last Name: Hara
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Siwen
    Last Name: Zhang
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Harrison Byron
    Last Name: Chong
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: Maristela
    Last Name: Onozato
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
  • First Name: Liron
    Last Name: Bar-Peled
    Affiliation: Center for Cancer Research, Massachusetts General Hospital, Boston, MA
  • First Name: A. John
    Last Name: Iafrate
    Affiliation: Department of Pathology, Massachusetts General Hospital, Boston, MA
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 12:23 Savannah Kandigian savannah.kandigian@yale.edu Session 6: Cancer Biology Molecular and histological characterization of NSCLC progression to leptomeningeal metastasis with comorbid intraparenchymal disease Savannah Kandigian Department of Pathology, Yale School of Medicine
  • First Name: Sampada
    Last Name: Chande
    Affiliation: Department of Pathology, Yale School of Medicine
  • First Name: Darin
    Last Name: Dolezal
    Affiliation: Department of Pathology, Yale School of Medicine
  • First Name: Tang
    Last Name: Tang
    Affiliation: Department of Pathology, Yale School of Medicine
  • First Name: Anna
    Last Name: Arnal-Estapé
    Affiliation: Department of Medical Oncology, Yale School of Medicine
  • First Name: Sally
    Last Name: Adua
    Affiliation: Department of Pathology, Yale School of Medicine
  • First Name: Stephanie
    Last Name: Cheok
    Affiliation: Department of Neurological Surgery, University of Southern California
  • First Name: Declan
    Last Name: McGuone
    Affiliation: Department of Pathology, Yale School of Medicine
  • First Name: Nicholas
    Last Name: Blondin
    Affiliation: Department of Neurology, Yale School of Medicine
  • First Name: Veronica
    Last Name: Chiang
    Affiliation: Department of Neurosurgery, Yale School of Medicine
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Department of Pathology, Yale School of Medicine
Abstract_Submission.pdf Yes Approved to be a Poster Presenter
Fri, 03/08/2024 - 13:42 Sampada Chande sampada.chande@yale.edu 6097722949 Session 6: Cancer Biology Characterization of tumor-neuron communication in lung adenocarcinoma brain metastasis Sampada Chande Department of Pathology, Yale University School of Medicine
  • First Name: Atsushi
    Last Name: Yamasaki
    Affiliation: Daiichi Sankyo Co., Ltd., Tokyo, Japan
  • First Name: Don
    Last Name: Nguyen
    Affiliation: Department of Pathology, Yale University School of Medicine
 Abstract_Submission.pdf No Approved to be a Speaker
Sun, 03/10/2024 - 12:47 Jessie Hao jessie.hao@emory.edu 4705423594 Session 6: Cancer Biology Co-occurring genomic alterations-guided in silico discovery of therapeutic vulnerability in lung adenocarcinoma Jessie Hao Department of Pharmacology and Chemical Biology, Emory University School of Medicine
  • First Name: Xiulei
    Last Name: Mo
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 00:35 Jianfeng Li jianfeng.li@emory.edu (412) 973-4647 Session 3: Immuno-oncology Uncovering the rewired IAP-JAK regulatory axis as an immune-dependent vulnerability of LKB1-mutant lung cancer Changfa Shu Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Jianfeng
    Last Name: Li
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Rui
    Last Name: Jin
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Dacheng
    Last Name: Fan
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Qiankun
    Last Name: Niu
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Danielle
    Last Name: Cicka
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Sean
    Last Name: Doyle
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Alafate
    Last Name: Wahafu
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Xi
    Last Name: Zheng
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Yuhong
    Last Name: Du
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Andrey A.
    Last Name: Ivanov
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Deon B
    Last Name: Doxie
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Kavita M
    Last Name: Dhodapkar
    Affiliation: Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA, USA
  • First Name: Jennifer
    Last Name: Carlisle
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Taofeek
    Last Name: Owonikoko
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Gabriel
    Last Name: Sica
    Affiliation: Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA
  • First Name: Yuan
    Last Name: Liu
    Affiliation: Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA
  • First Name: Suresh
    Last Name: Ramalingam
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Madhav V
    Last Name: Dhodapkar
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Wei
    Last Name: Zhou
    Affiliation: Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA
  • First Name: Xiulei
    Last Name: Mo
    Affiliation: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA
  • First Name: Haian
    Last Name: Fu
 Abstract_Submission.pdf No Approved to be a Speaker
Mon, 03/11/2024 - 13:40 Kelly Becht kelly.becht@yale.edu (603) 401-2345 Session 2: Health Disparities in Lung Cancer Disparities in Stereotactic Radiosurgery Receipt in Patients with Brain Metastases from Non-Small Cell Lung Cancer Kelly Becht Department of Therapeutic Radiology, Yale School of Medicine
  • First Name: Meghan
    Last Name: Lindsay
    Affiliation: Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine
  • First Name: Pamela
    Last Name: Soulos
    Affiliation: Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine
  • First Name: James
    Last Name: Hansen
    Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
  • First Name: Charu
    Last Name: Singh
    Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
  • First Name: Yi
    Last Name: An
    Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
  • First Name: Sanjay
    Last Name: Aneja
    Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
  • First Name: Sarah
    Last Name: Goldberg
    Affiliation: Department of Medicine, Section of Medical Oncology, Yale School of Medicine
  • First Name: Veronica
    Last Name: Chiang
    Affiliation: Department of Neurosurgery, Yale School of Medicine
  • First Name: Henry
    Last Name: Park
    Affiliation: Department of Therapeutic Radiology, Yale School of Medicine
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sat, 03/09/2024 - 12:58 Yuji Shibata yshibata@mdanderson.org 3462274948 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Pan-HER inhibition overcomes feedback adaptation resistance to KRAS G12C inhibition in KRAS G12C mutant non-small cell lung cancer Yuji Shibata Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Hibiki
    Last Name: Udagawa
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Monique
    Last Name: Nilsson
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Jacqulyne
    Last Name: Robichaux
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Ana
    Last Name: Galan-Cobo
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: David
    Last Name: Molkentine
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Junqin
    Last Name: He
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Qian
    Last Name: Huang
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Marcelo
    Last Name: Negrao
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Xiaoxing
    Last Name: Yu
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Alissa
    Last Name: Poteete
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Qian
    Last Name: Yu
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: Ferdinandos
    Last Name: Skoulidis
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
  • First Name: John
    Last Name: Heymach
    Affiliation: Department of Thoracic Head and Neck Medical Oncology, UT M.D. Anderson Cancer Center
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Sun, 03/10/2024 - 17:40 Jia Luo jia_luo@dfci.harvard.edu 6176323000 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Clinicopathologic and genomic features of patients with mucinous lung adenocarcinoma and response to systemic therapies Alessandro Di Federico DFCI
  • First Name: Lingzhi
    Last Name: Hong
    Affiliation: MDACC
  • First Name: Arielle
    Last Name: Elkrief
    Affiliation: MSKCC
  • First Name: Rohit
    Last Name: Thummalapalli
    Affiliation: MSKCC
  • First Name: Biagio
    Last Name: Ricciuti
    Affiliation: DFCI
  • First Name: Joao
    Last Name: Alessi
    Affiliation: DFCI
  • First Name: Pooja
    Last Name: Gogia
    Affiliation: MSKCC
  • First Name: Federica
    Last Name: Pecci
    Affiliation: DFCI
  • First Name: Malini
    Last Name: Gandhi
    Affiliation: DFCI
  • First Name: Marc
    Last Name: Ladanyi
    Affiliation: MSKCC
  • First Name: Jianjun
    Last Name: Zhang
    Affiliation: MDACC
  • First Name: Don
    Last Name: Gibbons
    Affiliation: MDACC
  • First Name: John
    Last Name: Heymach
    Affiliation: MDACC
  • First Name: Mizuki
    Last Name: Nishino
    Affiliation: DFCI
  • First Name: Lynette
    Last Name: Sholl
    Affiliation: BWH
  • First Name: Mark
    Last Name: Awad
    Affiliation: DFCI
  • First Name: Kathryn
    Last Name: Arbour
    Affiliation: MSKCC
  • First Name: Adam
    Last Name: Schoenfeld
    Affiliation: MSKCC
  • First Name: Natalie
    Last Name: Vokes
    Affiliation: MDACC
  • First Name: Jia
    Last Name: Luo
    Affiliation: DFCI
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 06:48 Elliott Brea elliott_brea@dfci.harvard.edu 8479221042 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Development and effectiveness of TROP2 CAR T in EGFRm NSCLC including in TROP2 ADC refractory settings Elliott Brea DFCI
  • First Name: Eric
    Last Name: Smith
    Affiliation: DFCI
  • First Name: David
    Last Name: Barbie
    Affiliation: DFCI
  • First Name: Sachiv
    Last Name: Chakravarti
    Affiliation: DFCI
  • First Name: Alexis
    Last Name: Mottram
    Affiliation: DFCI
  • First Name: Prafulla
    Last Name: Gokhale
    Affiliation: DFCI
  • First Name: Ken
    Last Name: Ng
    Affiliation: DFCI
  • First Name: Cloud
    Last Name: Paweletz
    Affiliation: DFCI
  • First Name: Pasi
    Last Name: Jänne
    Affiliation: DFCI
  • First Name: Simon
    Last Name: Baldacci
    Affiliation: DFCI
  • First Name: Elena
    Last Name: Ivanova
    Affiliation: DFCI
  • First Name: Ha
    Last Name: Vo
    Affiliation: DFCI
  • First Name: Tran
    Last Name: Thai
    Affiliation: DFCI
  • First Name: Timothy
    Last Name: Haggerty
    Affiliation: DFCI
 Abstract_Submission.pdf No Approved to be a Poster Presenter
Mon, 03/11/2024 - 13:59 Mustafa Al-Dulaimi mustafa_al-dulaimi@dfci.harvard.edu 12087180181 Session 6: Cancer Biology CDK8/19 Co-inhibition Enhances Osimertinib Efficacy in EGFR Mutant Non-Small Cell Lung Cancers (NSCLC) Mustafa Al-Dulaimi DFCI
  • First Name: Antja-Voy
    Last Name: Hartley
    Affiliation: DFCI
  • First Name: Simon
    Last Name: Baldacci
    Affiliation: DFCI
  • First Name: Matthew
    Last Name: Booker
    Affiliation: DFCI
  • First Name: Nathanael
    Last Name: Gray
    Affiliation: Stanford Cancer Institute
  • First Name: Michael
    Last Name: Tolsturokov
    Affiliation: DFCI
  • First Name: Pasi
    Last Name: Janne
    Affiliation: DFCI
 Abstract_Submission.pdf No Approved to be a Poster Presenter